Rpia

Vitrosens Biotechnology Inc. is a high-growth diagnostics innovator and manufacturer dedicated to providing a broad range of human and veterinary healthcare testing solutions. With more than 500 assays, the portfolio spans a vast array of diagnostic fields, including infectious and communicable diseases such as sexually transmitted, respiratory, gastrointestinal, and tropical illnesses, along with chronic and specialized parameters like cardiac and tumor markers, diabetes, kidney function, allergy, and inflammatory tests. The offering also addresses hormonal and metabolic needs with fertility, hormone, thyroid, and vitamin assays, in addition to TORCH panels, drugs of abuse testing, and other specialized categories.

Headquartered in Istanbul at the crossroads of Europe, the Middle East, Asia, and Africa, Vitrosens Biotechnology Inc. operates a cutting-edge manufacturing facility and a ministry-approved, officially certified R&D center. As the region's first MDSAP-certified IVD manufacturing facility, the company consistently meets the highest quality and regulatory compliance standards. A network of more than 200 partners in over 50 countries ensures that diagnostic tools remain accessible and responsive to evolving global requirements.

Customer relationship excellence is the north star, guiding every action and interaction. Vitrosens Biotechnology Inc. empowers healthcare professionals to make timely, data-driven decisions that ultimately improve human and animal health outcomes by continuously advancing research and production capabilities, maintaining a human-centered approach, and embracing innovation.